Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology
- 17 June 2005
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 57 (9) , 1415-1423
- https://doi.org/10.1016/j.addr.2005.01.016
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Expression of H C Subunits from Clostridium botulinum Types C and D and Their Evaluation as Candidate Vaccine Antigens in MiceInfection and Immunity, 2003
- A novel recombinant vaccine which protects mice against ricin intoxicationVaccine, 2002
- Did Bioweapons Test Cause a Deadly Smallpox Outbreak?Science, 2002
- Candidate Vaccine against Botulinum Neurotoxin Serotype A Derived from a Venezuelan Equine Encephalitis Virus Vector SystemInfection and Immunity, 2001
- Identifying the principal protective antigenic determinants of type A botulinum neurotoxinVaccine, 1998
- Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxinVaccine, 1997
- Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinumVaccine, 1996
- Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855–1296 with antitoxin antibodies from three host speciesProtein Journal, 1996
- Protection against inhalation toxicity of ricin and abrin by immunisationHuman & Experimental Toxicology, 1995
- Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriersVaccine, 1995